Pregabalin 75 mg is NOT appropriate for a 14-year-old girl weighing 56 kg
For a 14-year-old weighing 56 kg (≥30 kg), the appropriate pregabalin dosing is weight-based: start at 2.5 mg/kg/day divided into 2-3 doses, which can be titrated up to a maximum of 10 mg/kg/day (not to exceed 600 mg/day). 1
Correct Dosing Algorithm for This Patient
Initial Dose Calculation
- Starting dose: 2.5 mg/kg/day = 2.5 × 56 kg = 140 mg/day
- Divide into 2-3 doses: approximately 50 mg three times daily or 75 mg twice daily
- This aligns with FDA-approved pediatric dosing for patients ≥30 kg 1
Titration Schedule
- Week 1: Start at 2.5 mg/kg/day (140 mg/day total)
- Subsequent weeks: May increase approximately weekly based on response and tolerability
- Maximum dose: 10 mg/kg/day = 560 mg/day (not to exceed 600 mg/day) 1
Why 75 mg Alone is Problematic
The question asks about "75 mg" without specifying frequency. If this means:
75 mg once daily = 75 mg/day total = 1.3 mg/kg/day → Significantly underdosed (below the 2.5 mg/kg/day starting recommendation)
75 mg twice daily = 150 mg/day total = 2.7 mg/kg/day → Appropriate starting dose 1
75 mg three times daily = 225 mg/day total = 4 mg/kg/day → Acceptable but higher than typical starting dose
Critical Considerations
Weight-Based Dosing Requirements
- Pediatric patients weighing ≥30 kg require 2.5-10 mg/kg/day 1, 2
- Patients weighing <30 kg require 40% higher doses (3.5-14 mg/kg/day) due to higher weight-normalized clearance 1, 3
- This patient at 56 kg falls into the ≥30 kg category
Evidence Supporting This Approach
Research demonstrates that pregabalin 10 mg/kg/day showed statistically significant efficacy in pediatric patients aged 4-16 years with focal onset seizures, while 2.5 mg/kg/day showed numerical but not statistically significant improvement 4. The dose-response relationship supports starting at the lower end and titrating upward based on clinical response.
Common Pitfalls to Avoid
- Underdosing: Using adult fixed doses (e.g., 75 mg once daily) without weight-based calculation leads to subtherapeutic levels in pediatric patients
- Inadequate titration time: Allow at least 4 weeks at each dose level to assess efficacy 5
- Ignoring renal function: Pregabalin requires dose adjustment in renal impairment; verify normal kidney function 1
- Abrupt discontinuation: Always taper over minimum 1 week when stopping 1
Side Effect Profile
Most common adverse events in pediatric patients include somnolence (25.8% at 10 mg/kg/day), increased weight (13.4%), and increased appetite (10.3%) 4. These are dose-dependent and can be minimized with gradual titration 3.
Monitoring Parameters
- Assess efficacy and tolerability at each dose level
- Monitor for dizziness and sedation, which are dose-dependent 5
- Verify creatinine clearance if any concern for renal impairment 1
- Duration of adequate trial: 4 weeks 5
The prescriber should clarify the intended dosing frequency and ensure the total daily dose aligns with weight-based recommendations of 2.5-10 mg/kg/day for this 56 kg adolescent patient.